June 5, 2022
Tag: rectal cancer
June 5, 2022
Medscape: ‘Great Optimism’ Over Complete Responses in dMMR Rectal Cancer
June 5, 2022
New York Times: A Cancer Trial’s Unexpected Result: Remission in Every Patient
June 5, 2022
Precision Oncology News: Rectal Cancer Patient Subset Shows Complete Response to Immunotherapy in Small Study
June 5, 2022
Sanoff offers perspective on a promising rectal cancer study in the New England Journal of Medicine
Hanna K. Sanoff, MD, MPH, is the author of a viewpoint that provides a perspective on the evolving treatment of rectal cancer in light of findings from a phase II clinical trial using the drug dostarlimab.
January 5, 2012
UNC GI oncologists author editorial in the Journal of Clinical Oncology
UNC Lineberger GI Oncology program directors Joel Tepper, MD, and Bert O’Neil, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Tepper is the Hector McLean Distinguished Professor of Cancer Research. O’Neil is associate professor of medicine.